tiprankstipranks
Trending News
More News >
Race Oncology Ltd. (AU:RAC)
ASX:RAC
Australian Market
Advertisement

Race Oncology Ltd. (RAC) Price & Analysis

Compare
23 Followers

RAC Stock Chart & Stats


Race Oncology Ltd. News

RAC FAQ

What was Race Oncology Ltd.’s price range in the past 12 months?
Race Oncology Ltd. lowest share price was AU$0.92 and its highest was AU$1.94 in the past 12 months.
    What is Race Oncology Ltd.’s market cap?
    Race Oncology Ltd.’s market cap is AU$208.49M.
      When is Race Oncology Ltd.’s upcoming earnings report date?
      Race Oncology Ltd.’s upcoming earnings report date is Mar 04, 2026 which is in 187 days.
        How were Race Oncology Ltd.’s earnings last quarter?
        Race Oncology Ltd. released its earnings results on Aug 22, 2025. The company reported -AU$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.03.
          Is Race Oncology Ltd. overvalued?
          According to Wall Street analysts Race Oncology Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Race Oncology Ltd. pay dividends?
            Race Oncology Ltd. does not currently pay dividends.
            What is Race Oncology Ltd.’s EPS estimate?
            Race Oncology Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Race Oncology Ltd. have?
            Race Oncology Ltd. has 173,744,380 shares outstanding.
              What happened to Race Oncology Ltd.’s price movement after its last earnings report?
              Race Oncology Ltd. reported an EPS of -AU$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Race Oncology Ltd.?
                Currently, no hedge funds are holding shares in AU:RAC

                Race Oncology Ltd. Stock Smart Score

                Company Description

                Race Oncology Ltd.

                Race Oncology Ltd. (RAC) is an Australian pharmaceutical company focused on the development and commercialization of oncology therapies. The company is engaged in the research and development of innovative cancer treatments, with a particular emphasis on the use of its flagship drug, bisantrene, for the treatment of various cancer types. Race Oncology operates within the biotechnology and pharmaceutical sectors, aiming to provide effective solutions to unmet medical needs in oncology.

                Race Oncology Ltd. (RAC) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Alterity Therapeutics
                Prescient Therapeutics Limited
                EZZ Life Science Holdings Ltd.
                Recce Pharmaceuticals Ltd.
                Arovella Therapeutics Limited

                Ownership Overview

                0.27%99.73%
                Mutual Funds
                ― Other Institutional Investors
                99.73% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis